Combined treatment with extracorporeal shockwaves therapy and an herbal formulation for activation of penile progenitor cells and antioxidant activity in diabetic erectile dysfunction
- PMID: 32420147
- PMCID: PMC7214964
- DOI: 10.21037/tau.2020.01.23
Combined treatment with extracorporeal shockwaves therapy and an herbal formulation for activation of penile progenitor cells and antioxidant activity in diabetic erectile dysfunction
Abstract
Background: A Korean herbal formulation named KH-204 was reported to have an antioxidant effect in our previous study. We hypothesized that Low-intensity extracorporeal shockwave therapy (Li-ESWT) combined with KH-204 would accelerate the treatment of erectile dysfunction (ED) by enhancing antioxidant. We investigated the synergistic effect of Li-ESWT and KH-204 for ED and explored the mechanism.
Methods: Human umbilical vein endothelial cells (HUVEC) were treated with KH-204 and LI-ESWT in vitro. Fifty 5-week-old male Sprague Dawley rats received an intraperitoneal injection of 5-ethynyl-20-deoxyuridine (EdU) which can label live cells, and were randomly divided into five groups: (I) normal; (II) diabetes mellitus-associated erectile dysfunction (DMED); (III) DMED + KH-204; (IV) DMED + Li-ESWT; and (V) DMED + KH-204/Li-ESWT. Li-ESWT treatment was repeated three times a week every other day for four weeks in group 4 and 5. Meanwhile, rats in group 3 and 5 were orally fed 400 mg/kg of KH-204 daily for 1 month. Following a 1-week washout period, penile tissues were evaluated by immunostaining and Western blotting.
Results: KH-204 combined with Li-ESWT improved intracavernosal pressure (ICP) in DMED rats. Li-ESWT/KH-204 stimulated HUVEC tube formation and promoted proliferation. Li-ESWT drove progenitor cells to migrate to penile tissue and KH-204 protected penile progenitor cells in the corpus cavernosum. Oxidative stress was relieved by KH-204/Li-ESWT. Treatment with KH-204/Li-ESWT protected penile progenitor cells, which were recruited to the corpus cavernosum by Li-ESWT, from apoptosis via its antioxidant activity. KH-204/Li-ESWT protected penile tissue from oxidative stress by improving the expression of nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1), increasing superoxide dismutase (SOD), decreasing 8-hydroxy-20-deoxyguanosine (8-OHdG), and reducing apoptosis. KH-204/Li-ESWT promoted stromal derived factor-1 (SDF-1) and platelet endothelial cell adhesion molecule-1 (PECAM-1) in DMED rats.
Conclusions: KH-204 protected penile progenitor cells, which were recruited to the corpus cavernosum by Li-ESWT, from apoptosis via its antioxidant activity. The combination of Li-ESWT and KH-204 as a synergy therapy could be a potential and effective treatment for DMED.
Keywords: Low-intensity extracorporeal shockwave therapy; antioxidant; diabetes mellitus; erectile dysfunction (ED); herbal formulation; progenitor cells.
2020 Translational Andrology and Urology. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau.2020.01.23). The authors have no conflicts of interest to declare.
Figures







Similar articles
-
In Situ Activation of Penile Progenitor Cells With Low-Intensity Extracorporeal Shockwave Therapy.J Sex Med. 2017 Apr;14(4):493-501. doi: 10.1016/j.jsxm.2017.02.004. Epub 2017 Mar 1. J Sex Med. 2017. PMID: 28258952
-
The effect of low-intensity extracorporeal shockwave therapy in an obesity-associated erectile dysfunction rat model.BJU Int. 2018 Jul;122(1):133-142. doi: 10.1111/bju.14202. Epub 2018 Apr 17. BJU Int. 2018. PMID: 29573106 Free PMC article.
-
Synergistic effects of extracorporeal shockwave therapy and modified Ojayeonjonghwan on erectile dysfunction in an animal model of diabetes.Investig Clin Urol. 2019 Jul;60(4):285-294. doi: 10.4111/icu.2019.60.4.285. Epub 2019 Jun 5. Investig Clin Urol. 2019. PMID: 31294138 Free PMC article.
-
The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies.J Sex Med. 2019 Feb;16(2):168-194. doi: 10.1016/j.jsxm.2018.12.016. J Sex Med. 2019. PMID: 30770067
-
Low-intensity extracorporeal shockwave therapy for diabetic men with erectile dysfunction: A systematic scoping review.Andrology. 2023 Feb;11(2):270-281. doi: 10.1111/andr.13197. Epub 2022 Jun 8. Andrology. 2023. PMID: 35642619
Cited by
-
The application of extracorporeal shock wave therapy on stem cells therapy to treat various diseases.Stem Cell Res Ther. 2024 Aug 26;15(1):271. doi: 10.1186/s13287-024-03888-w. Stem Cell Res Ther. 2024. PMID: 39183302 Free PMC article. Review.
-
Extracorporeal shock wave therapy combined with engineered mesenchymal stem cells expressing stromal cell-derived factor-1 can improve erectile dysfunction in streptozotocin-induced diabetic rats.Transl Androl Urol. 2021 Jun;10(6):2362-2372. doi: 10.21037/tau-21-79. Transl Androl Urol. 2021. PMID: 34295723 Free PMC article.
-
Stem cell assisted low-intensity shockwave for erectile dysfunction treatment: Current perspective.Regen Ther. 2024 Nov 20;26:1150-1158. doi: 10.1016/j.reth.2024.11.006. eCollection 2024 Jun. Regen Ther. 2024. PMID: 39640922 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous